1. Home
  2. CHEK vs MEGL Comparison

CHEK vs MEGL Comparison

Compare CHEK & MEGL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CHEK
  • MEGL
  • Stock Information
  • Founded
  • CHEK 2004
  • MEGL 2016
  • Country
  • CHEK Israel
  • MEGL Hong Kong
  • Employees
  • CHEK N/A
  • MEGL N/A
  • Industry
  • CHEK Medical Electronics
  • MEGL Finance: Consumer Services
  • Sector
  • CHEK Health Care
  • MEGL Finance
  • Exchange
  • CHEK Nasdaq
  • MEGL Nasdaq
  • Market Cap
  • CHEK 9.0M
  • MEGL 9.0M
  • IPO Year
  • CHEK 2015
  • MEGL 2022
  • Fundamental
  • Price
  • CHEK $0.89
  • MEGL $0.51
  • Analyst Decision
  • CHEK
  • MEGL
  • Analyst Count
  • CHEK 0
  • MEGL 0
  • Target Price
  • CHEK N/A
  • MEGL N/A
  • AVG Volume (30 Days)
  • CHEK 220.4K
  • MEGL 401.2K
  • Earning Date
  • CHEK 02-18-2025
  • MEGL 10-30-2024
  • Dividend Yield
  • CHEK N/A
  • MEGL N/A
  • EPS Growth
  • CHEK N/A
  • MEGL N/A
  • EPS
  • CHEK N/A
  • MEGL N/A
  • Revenue
  • CHEK N/A
  • MEGL $1,976,138.00
  • Revenue This Year
  • CHEK N/A
  • MEGL N/A
  • Revenue Next Year
  • CHEK N/A
  • MEGL N/A
  • P/E Ratio
  • CHEK N/A
  • MEGL N/A
  • Revenue Growth
  • CHEK N/A
  • MEGL 67.75
  • 52 Week Low
  • CHEK $0.56
  • MEGL $0.41
  • 52 Week High
  • CHEK $3.45
  • MEGL $1.38
  • Technical
  • Relative Strength Index (RSI)
  • CHEK 42.03
  • MEGL 42.26
  • Support Level
  • CHEK $0.81
  • MEGL $0.47
  • Resistance Level
  • CHEK $1.07
  • MEGL $0.61
  • Average True Range (ATR)
  • CHEK 0.10
  • MEGL 0.05
  • MACD
  • CHEK -0.06
  • MEGL -0.01
  • Stochastic Oscillator
  • CHEK 14.05
  • MEGL 23.63

About CHEK Check-Cap Ltd.

Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.

About MEGL Magic Empire Global Limited

Magic Empire Global Ltd is a financial services provider in Hong Kong which principally engage in the provision of corporate finance advisory services and underwriting services. The companys offerings mainly comprise of IPO sponsorship services, Financial advisory and independent financial advisory services, Compliance advisory services, Underwriting services, Corporate service.

Share on Social Networks: